BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lamothe B, Aggarwal BB. Ectopic expression of Bcl-2 and Bcl-xL inhibits apoptosis induced by TNF-related apoptosis-inducing ligand (TRAIL) through suppression of caspases-8, 7, and 3 and BID cleavage in human acute myelogenous leukemia cell line HL-60. J Interferon Cytokine Res. 2002;22:269-279. [PMID: 11911810 DOI: 10.1089/107999002753536248] [Cited by in Crossref: 41] [Cited by in F6Publishing: 32] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 von Haefen C, Wendt J, Semini G, Sifringer M, Belka C, Radetzki S, Reutter W, Daniel PT, Danker K. Synthetic glycosidated phospholipids induce apoptosis through activation of FADD, caspase-8 and the mitochondrial death pathway. Apoptosis 2011;16:636-51. [DOI: 10.1007/s10495-011-0592-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
2 Subbiah V, Brown RE, Buryanek J, Trent J, Ashkenazi A, Herbst R, Kurzrock R. Targeting the apoptotic pathway in chondrosarcoma using recombinant human Apo2L/TRAIL (dulanermin), a dual proapoptotic receptor (DR4/DR5) agonist. Mol Cancer Ther 2012;11:2541-6. [PMID: 22914439 DOI: 10.1158/1535-7163.MCT-12-0358] [Cited by in Crossref: 44] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
3 Georgakis GV, Li Y, Humphreys R, Andreeff M, O'brien S, Younes M, Carbone A, Albert V, Younes A. Activity of selective fully human agonistic antibodies to the TRAIL death receptors TRAIL-R1 and TRAIL-R2 in primary and cultured lymphoma cells: induction of apoptosis and enhancement of doxorubicin- and bortezomib-induced cell death. Br J Haematol 2005;130:501-10. [DOI: 10.1111/j.1365-2141.2005.05656.x] [Cited by in Crossref: 133] [Cited by in F6Publishing: 103] [Article Influence: 7.8] [Reference Citation Analysis]
4 Kotelkin A, Prikhod'ko EA, Cohen JI, Collins PL, Bukreyev A. Respiratory syncytial virus infection sensitizes cells to apoptosis mediated by tumor necrosis factor-related apoptosis-inducing ligand. J Virol 2003;77:9156-72. [PMID: 12915532 DOI: 10.1128/jvi.77.17.9156-9172.2003] [Cited by in Crossref: 90] [Cited by in F6Publishing: 65] [Article Influence: 4.7] [Reference Citation Analysis]
5 Jin Z, McDonald ER 3rd, Dicker DT, El-Deiry WS. Deficient tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor transport to the cell surface in human colon cancer cells selected for resistance to TRAIL-induced apoptosis. J Biol Chem. 2004;279:35829-35839. [PMID: 15155747 DOI: 10.1074/jbc.M405538200] [Cited by in Crossref: 165] [Cited by in F6Publishing: 75] [Article Influence: 9.2] [Reference Citation Analysis]
6 Managit C, Sakurai H, Saiki I. Ethanolic extract of Thevetia peruviana flowers enhances TNF-α and TRAIL-induced apoptosis of human cervical cancer cells via intrinsic and extrinsic pathways. Oncol Lett 2017;13:2791-8. [PMID: 28454468 DOI: 10.3892/ol.2017.5748] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
7 D'agostino L, Giordano A. NSP 5a3a: a potential novel cancer target in head and neck carcinoma. Oncotarget 2010;1:423-35. [PMID: 21311098 DOI: 10.18632/oncotarget.100913] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
8 Souček K, Pacherník J, Kubala L, Vondráček J, Hofmanová J, Kozubík A. Transforming growth factor-β1 inhibits all-trans retinoic acid-induced apoptosis. Leukemia Research 2006;30:607-23. [DOI: 10.1016/j.leukres.2005.09.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
9 Kazhdan I, Marciniak RA. Death receptor 4 (DR4) efficiently kills breast cancer cells irrespective of their sensitivity to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). Cancer Gene Ther 2004;11:691-8. [DOI: 10.1038/sj.cgt.7700747] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
10 Nagaoka I, Niyonsaba F, Tsutsumi-Ishii Y, Tamura H, Hirata M. Evaluation of the effect of human beta-defensins on neutrophil apoptosis. Int Immunol 2008;20:543-53. [PMID: 18308714 DOI: 10.1093/intimm/dxn012] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 3.8] [Reference Citation Analysis]
11 Younes M, Georgakis GV, Rahmani M, Beer D, Younes A. Functional expression of TRAIL receptors TRAIL-R1 and TRAIL-R2 in esophageal adenocarcinoma. European Journal of Cancer 2006;42:542-7. [DOI: 10.1016/j.ejca.2005.11.013] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
12 Bortul R, Tazzari PL, Cappellini A, Tabellini G, Billi AM, Bareggi R, Manzoli L, Cocco L, Martelli AM. Constitutively active Akt1 protects HL60 leukemia cells from TRAIL-induced apoptosis through a mechanism involving NF-kappaB activation and cFLIP(L) up-regulation. Leukemia. 2003;17:379-389. [PMID: 12592338 DOI: 10.1038/sj.leu.2402793] [Cited by in Crossref: 78] [Cited by in F6Publishing: 69] [Article Influence: 4.1] [Reference Citation Analysis]
13 Yun X, Wu Y, Yao L, Zong H, Hong Y, Jiang J, Yang J, Zhang Z, Gu J. CDK11(p58) protein kinase activity is associated with Bcl-2 down-regulation in pro-apoptosis pathway. Mol Cell Biochem. 2007;304:213-218. [PMID: 17516030 DOI: 10.1007/s11010-007-9502-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
14 Aggarwal BB, Bhardwaj U, Takada Y. Regulation of TRAIL-Induced Apoptosis by Ectopic Expression of Antiapoptotic Factors. TRAIL (TNF-Related Apoptosis-Inducing Ligand). Elsevier; 2004. pp. 453-83. [DOI: 10.1016/s0083-6729(04)67023-3] [Cited by in Crossref: 53] [Cited by in F6Publishing: 15] [Article Influence: 2.9] [Reference Citation Analysis]
15 Sprick MR, Walczak H. The interplay between the Bcl-2 family and death receptor-mediated apoptosis. Biochim Biophys Acta. 2004;1644:125-132. [PMID: 14996497 DOI: 10.1016/j.bbamcr.2003.11.002] [Cited by in Crossref: 145] [Cited by in F6Publishing: 138] [Article Influence: 8.1] [Reference Citation Analysis]
16 Song K, Benhaga N, Anderson RL, Khosravi-Far R. Transduction of tumor necrosis factor-related apoptosis-inducing ligand into hematopoietic cells leads to inhibition of syngeneic tumor growth in vivo. Cancer Res 2006;66:6304-11. [PMID: 16778207 DOI: 10.1158/0008-5472.CAN-05-3501] [Cited by in Crossref: 24] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
17 Chen LH, Liu XS, Wang WY, Han WN, Pan BR, Jin BQ. Localization of TRAIL/TRAILR in fetal pancreas. World J Gastroenterol 2003; 9(2): 334-337 [PMID: 12532461 DOI: 10.3748/wjg.v9.i2.334] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
18 Kidson A, Rubio-pomar FJ, Van Knegsel A, Van Tol HTA, Hazeleger W, Ducro-steverink DWB, Colenbrander B, Dieleman SJ, Bevers MM. Quality of porcine blastocysts produced in vitro in the presence or absence of GH. Reproduction 2004;127:165-77. [DOI: 10.1530/rep.1.00086] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 1.4] [Reference Citation Analysis]
19 Meng HT, Li L, Liu H, Wang Y, Li GC, Qian WB. Homoharringtonine acts synergistically with SG235-TRAIL, a conditionally replicating adenovirus, in human leukemia cell lines. Acta Pharmacol Sin 2009;30:1529-36. [PMID: 19820719 DOI: 10.1038/aps.2009.147] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
20 Nagaoka I, Suzuki K, Niyonsaba F, Tamura H, Hirata M. Modulation of neutrophil apoptosis by antimicrobial peptides. ISRN Microbiol 2012;2012:345791. [PMID: 23724322 DOI: 10.5402/2012/345791] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
21 Kaliberov S, Stackhouse MA, Kaliberova L, Zhou T, Buchsbaum DJ. Enhanced apoptosis following treatment with TRA-8 anti-human DR5 monoclonal antibody and overexpression of exogenous Bax in human glioma cells. Gene Ther 2004;11:658-67. [PMID: 14973547 DOI: 10.1038/sj.gt.3302215] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
22 Dandrea T, Hellmold H, Jonsson C, Zhivotovsky B, Hofer T, Wärngård L, Cotgreave I. The transcriptosomal response of human A549 lung cells to a hydrogen peroxide-generating system: relationship to DNA damage, cell cycle arrest, and caspase activation. Free Radical Biology and Medicine 2004;36:881-96. [DOI: 10.1016/j.freeradbiomed.2003.12.014] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 2.6] [Reference Citation Analysis]
23 Lee YJ, Lee JH, Moon JH, Park SY. Overcoming hypoxic-resistance of tumor cells to TRAIL-induced apoptosis through melatonin. Int J Mol Sci 2014;15:11941-56. [PMID: 25000265 DOI: 10.3390/ijms150711941] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
24 Oehme I, Bösser S, Zörnig M. Agonists of an ecdysone-inducible mammalian expression system inhibit Fas Ligand- and TRAIL-induced apoptosis in the human colon carcinoma cell line RKO. Cell Death Differ 2006;13:189-201. [PMID: 16082389 DOI: 10.1038/sj.cdd.4401730] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 1.8] [Reference Citation Analysis]
25 Smolewski P, Darzynkiewicz Z, Robak T. Caspase-mediated cell death in hematological malignancies: theoretical considerations, methods of assessment, and clinical implications. Leuk Lymphoma 2003;44:1089-104. [PMID: 12916860 DOI: 10.1080/1042819031000077007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
26 Almasan A, Ashkenazi A. Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy. Cytokine & Growth Factor Reviews 2003;14:337-48. [DOI: 10.1016/s1359-6101(03)00029-7] [Cited by in Crossref: 400] [Cited by in F6Publishing: 160] [Article Influence: 21.1] [Reference Citation Analysis]
27 Nagamoto Y, Takayama K, Tashiro K, Tateno C, Sakurai F, Tachibana M, Kawabata K, Ikeda K, Tanaka Y, Mizuguchi H. Efficient Engraftment of Human Induced Pluripotent Stem Cell-Derived Hepatocyte-Like Cells in uPA/SCID Mice by Overexpression of FNK, a Bcl-xL Mutant Gene. Cell Transplant. 2015;24:1127-1138. [PMID: 24806294 DOI: 10.3727/096368914x681702] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
28 Belkahla H, Herlem G, Picaud F, Gharbi T, Hémadi M, Ammar S, Micheau O. TRAIL–NP hybrids for cancer therapy: a review. Nanoscale 2017;9:5755-68. [DOI: 10.1039/c7nr01469d] [Cited by in Crossref: 24] [Cited by in F6Publishing: 10] [Article Influence: 4.8] [Reference Citation Analysis]
29 Roucou X, Giannopoulos PN, Zhang Y, Jodoin J, Goodyer CG, LeBlanc A. Cellular prion protein inhibits proapoptotic Bax conformational change in human neurons and in breast carcinoma MCF-7 cells. Cell Death Differ. 2005;12:783-795. [PMID: 15846375 DOI: 10.1038/sj.cdd.4401629] [Cited by in Crossref: 110] [Cited by in F6Publishing: 105] [Article Influence: 6.5] [Reference Citation Analysis]
30 Hwang MK, Ryu BJ, Kim SH. AW00179 potentiates TRAIL-mediated death of human lung cancer H1299 cells through ROS-JNK-c-Jun-mediated up-regulation of DR5 and down-regulation of anti-apoptotic molecules. Amino Acids 2012;43:1679-87. [PMID: 22354145 DOI: 10.1007/s00726-012-1249-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
31 Song K, Mariappan R, Khosravi-Far R. Analysis of TNF-related apoptosis-inducing ligand in vivo through bone marrow transduction and transplantation. Methods Enzymol 2008;446:315-31. [PMID: 18603131 DOI: 10.1016/S0076-6879(08)01619-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
32 Meng XW, Lee S, Dai H, Loegering D, Yu C, Flatten K, Schneider P, Dai NT, Kumar SK, Smith BD, Karp JE, Adjei AA, Kaufmann SH. MCL-1 as a Buffer for Proapoptotic BCL-2 Family Members during TRAIL-induced Apoptosis. Journal of Biological Chemistry 2007;282:29831-46. [DOI: 10.1074/jbc.m706110200] [Cited by in Crossref: 88] [Cited by in F6Publishing: 47] [Article Influence: 5.9] [Reference Citation Analysis]